Pacalin, Naomi M. http://orcid.org/0000-0001-6870-2090
Steinhart, Zachary
Shi, Quanming
Belk, Julia A. http://orcid.org/0000-0003-4724-6158
Dorovskyi, Dmytro
Kraft, Katerina
Parker, Kevin R.
Shy, Brian R. http://orcid.org/0000-0001-9569-3708
Marson, Alexander http://orcid.org/0000-0002-2734-5776
Chang, Howard Y. http://orcid.org/0000-0002-9459-4393
Funding for this research was provided by:
Scleroderma Research Foundation (NA)
Howard Hughes Medical Institute (NA, Hanna Gray Fellow)
Foundation for the National Institutes of Health (T32GM141819, K08CA273529, L30TR002983)
National Science Foundation (GRFP)
UCSF Scholars At Risk program
Parker Institute for Cancer Immunotherapy (PICI), Lloyd J. Old STAR award from the Cancer Research Institute (CRI), Simons Foundation, CRISPR Cures for Cancer Initiative
Article History
Received: 15 November 2022
Accepted: 19 March 2024
First Online: 17 May 2024
Competing interests
: H.Y.C. is a co-founder of Accent Therapeutics, Boundless Bio, Cartography Biosciences and Orbital Therapeutics and is an advisor to 10x Genomics, Arsenal Biosciences and Spring Discovery. A.M. is a co-founder of Arsenal Biosciences, Site Tx, Spotlight Therapeutics and Survey Genomics; serves on the boards of directors at Site Tx, Spotlight Therapeutics and Survey Genomics; is a member of the scientific advisory boards of Arsenal Biosciences, Site Tx, Spotlight Therapeutics, Survey Genomics, NewLimit, Amgen, Tenaya and Lightcast; owns stock in Arsenal Biosciences, Site Tx, Spotlight Therapeutics, NewLimit, Survey Genomics, Tenaya and Lightcast; and has received fees from Arsenal Biosciences, Spotlight Therapeutics, Site Tx, NewLimit, 23andMe, PACT Pharma, Juno Therapeutics, Tenaya, Survey Genomics, Lightcast, Gilead, Trizell, Vertex, Merck, Amgen, Genentech, AlphaSights, Rupert Case Management, Bernstein, GLG, ClearView Healthcare Partners and ALDA. A.M. is an investor in and an informal advisor to Offline Ventures and is a client of EPIQ. The Marson laboratory has received research support from Juno Therapeutics, Epinomics, Sanofi, GlaxoSmithKline, Gilead and Anthem and reagents from Illumina and GenScript. K.R.P. is a co-founder of, is employed by and serves on the board of directors of Cartography Biosciences. B.R.S. is a member of the scientific advisory board for Kano Therapeutics.